125 The androgen receptor agonist, Cl-4AS-1, possesses unique effects on breast cancer cells: A potential therapeutic benefit. (September 2015) - Ahram, M.; Mustafa, E.; Hammad, S. Abu; Hodhod, M.; Zihlif, M.